Citadel Advisors - HEMISPHERX BIOPHARMA INC ownership

Quarter-by-quarter ownership
Citadel Advisors ownership history of HEMISPHERX BIOPHARMA INC
ValueSharesWeighting
Q2 2016$5,000
-83.9%
45,788
-80.6%
0.00%
Q1 2016$31,000
+19.2%
235,617
-25.7%
0.00%
Q4 2015$26,000
+23.8%
317,251
+379.1%
0.00%
Q3 2014$21,000
+133.3%
66,222
+140.8%
0.00%
Q2 2014$9,000
-91.7%
27,499
-89.8%
0.00%
Q1 2014$108,000
+332.0%
269,152
+150.9%
0.00%
Q3 2013$25,000
+525.0%
107,276
+547.5%
0.00%
Q2 2013$4,00016,5680.00%
Other shareholders
HEMISPHERX BIOPHARMA INC shareholders Q3 2016
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 156,500$41,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 524,476$139,0000.00%
Investors Capital Advisory Services 17,000$4,0000.00%
Joel Isaacson & Co., LLC 15,500$4,0000.00%
CITY HOLDING CO 5,000$1,0000.00%
UBS AG 10,110$3,0000.00%
NOMURA HOLDINGS INC 1,400$00.00%
DIMENSIONAL FUND ADVISORS LP 288,100$76,0000.00%
BANK OF AMERICA CORP /DE/ 30,506$8,0000.00%
WELLS FARGO & COMPANY/MN 10,396$3,0000.00%
View complete list of HEMISPHERX BIOPHARMA INC shareholders